EGFR and neoplasm: Furthermore, rechallenging of the mice that rejected the tumor upon treatment with EGFR-targeted 4-1BB-agonistic trimerbody with fresh CT26mock cells failed to allow tumor implantation, thus indicating that long-lasting tumor-specific memory had been established.